Fierce Pharma Asia—Enhertu’s HER2-low breast cancer win; Takeda’s $2B gene therapy pact; Xtandi march-in campaign February 25, 2022 Auto Bot News 0 Fierce Pharma Asia—Enhertu’s HER2-low breast cancer win; Takeda’s $2B gene therapy pact; Xtandi march-in campaign aliu Fri, 02/25/2022 – 06:53
